Pre-market vol spike 18 Mar 2026: FCG.AX Freedom Care ASX A$0.059, liquidity

A pre-market volume spike is pushing attention to FCG.AX stock on 18 Mar 2026 after trades hit an early day high A$0.059 and volume surged to 1,184,838 shares versus an average of 30,060. The current last trade is A$0.037 in the ASX pre-market session, producing a rel. volume of 39.42x and signalling heightened liquidity. We use Meyka AI-powered market analysis platform to connect the volume burst to valuation, short-term targets and trading risks for Freedom Care Group Holdings Ltd. (ASX: FCG.AX).

FCG.AX stock: Pre-market volume and trade data

Volume for FCG.AX stock is 1,184,838 versus an average volume of 30,060, a surge that raised the rel. volume to 39.42x and drove an open at A$0.059 before settling near A$0.037; that jump is the primary reason traders flagged the name in pre-market flows.

FCG.AX stock: Price action, intraday levels and liquidity

Price action shows a day low A$0.037 and day high A$0.059 with a 52-week range from A$0.037 to A$0.21, indicating high volatility after the volume spike; the large gap between the 50-day average (A$0.037) and 200-day average (A$0.11) emphasises short-term momentum over longer-term trend.

FCG.AX stock: Fundamentals and valuation snapshot

Freedom Care Group (FCG.AX) reports EPS A$0.01 and a trailing PE near 4.50, with market capitalisation of A$4,007,738 and shares outstanding 108,317,248; price-to-sales is 0.21 and price-to-book is 0.75, suggesting low market pricing relative to book value despite mixed operating margins.

FCG.AX stock: Meyka AI grade and model view

Meyka AI rates FCG.AX with a score out of 100: 69.77 (Grade B, SUGGESTION: HOLD); this grade factors S&P 500 and sector comparisons, financial growth, key metrics, forecasts and analyst inputs. Meyka AI’s forecast model projects a medium-term reference price of A$0.09 versus the current A$0.037, implying an upside of 143.24%, noting forecasts are model-based projections and not guarantees.

FCG.AX stock: Sector context and broker-style price targets

Healthcare peers trade at an average PE near 27.27, so FCG.AX stock is trading at a deep discount on PE metrics; market participants frame near-term targets at A$0.06 (short-term) and A$0.15 (longer-term) based on recovery scenarios, with implied moves of 62.16% and 305.41% respectively from A$0.037.

FCG.AX stock: Risks, catalysts and trading strategy

Key risks for FCG.AX stock include thin order books outside the spike, NDIS policy shifts, and operational margins; catalysts are fresh contract wins, quarterly earnings surprises, and further liquidity that narrows spreads, so traders should size positions and use limit orders in the ASX pre-market session.

Final Thoughts

The pre-market volume spike on 18 Mar 2026 places FCG.AX stock on active watch lists after 1,184,838 shares traded and an early high of A$0.059; the immediate signal is liquidity-driven interest rather than clear fundamental news. Valuation is mixed: trailing PE near 4.50, price-to-book 0.75, and a market cap of A$4,007,738 make the stock cheap by traditional multiples but volatile by liquidity and trading pattern. Meyka AI’s forecast model projects A$0.09 as a medium-term reference, an implied upside of 143.24% from the current A$0.037, while our conservative short-term target is A$0.06 (up 62.16%). These forecasts are model-based projections and not guarantees; active traders should watch continued volume, ASX order depth and any company updates on the Freedom Care website. For quick reference see the company site Freedom Care Group and the Meyka stock page for live metrics and alerts at Meyka FCG.AX.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.